Target Name: LOC100506207
NCBI ID: G100506207
Review Report on LOC100506207 Target / Biomarker Content of Review Report on LOC100506207 Target / Biomarker
LOC100506207
Other Name(s): Uncharacterized LOC100506207, transcript variant 1 | uncharacterized LOC100506207 | LOC100506207 variant 1

LOC100506207: A Drug Target / Disease Biomarker

LOC100506207 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a critical role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

LOC100506207 is of particular interest as a potential drug target or biomarker because of its involvement in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroinclusions, which are thought to contribute to the symptoms of these diseases.

One of the key challenges in targeting LOC100506207 as a drug or biomarker is its widespread expression in the brain, which makes it difficult to selectively target the protein. However, recent studies have identified potential LOC100506207-specific antibodies that can be used for screening and preclinical testing.

In addition to its potential use as a drug target, LOC100506207 is also a promising biomarker for several neurodegenerative diseases. The loss of LOC100506207 has been observed in the brains of individuals with Alzheimer's disease, and overexpression of the protein has been shown to exacerbate the symptoms of this disease. Similarly, LOC100506207 has been shown to be reduced in the brains of individuals with Parkinson's disease, and elevated levels of the protein have been associated with the development of this disease.

Another promising application of LOC100506207 as a biomarker is its potential use in the diagnosis of neurodegenerative diseases. The loss of LOC100506207 has been observed in the brains of individuals with a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, LOC100506207 may be a useful biomarker for the diagnosis and monitoring of these conditions.

In conclusion, LOC100506207 is a protein that is of interest as a drug target or biomarker due to its involvement in several neurodegenerative diseases. The protein has been shown to be involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. In addition, LOC100506207 is a widespread protein that is expressed in various tissues of the body, including the brain, heart, and kidneys, which makes it difficult to selectively target the protein. Therefore, LOC100506207 may be a promising target for new therapies and diagnostic tools in the treatment of neurodegenerative diseases.

Protein Name: Uncharacterized LOC100506207

The "LOC100506207 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100506207 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531